Page last updated: 2024-11-08

chrysophanol 8-o-glucoside

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

chrysophanol 8-O-glucoside: has anti-hepatitis B virus activity; also has antiplatelet and anticoagulant activities; isolated from Rheum palmatum [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

chrysophanol 8-O-beta-D-glucoside : A beta-D-glucoside in which the aglycone species is chrysophanol, the glycosidic linkage being to the hydroxy group at C-8. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

FloraRankFlora DefinitionFamilyFamily Definition
RheumgenusA plant genus of the family POLYGONACEAE. Members contain chrysophanic acid, rhein, EMODIN, and other ANTHRAQUINONES. The roots were formerly used as PURGATIVES.[MeSH]PolygonaceaeThe only family of the buckwheat order (Polygonales) of dicotyledonous flowering plants. It has 40 genera of herbs, shrubs, and trees.[MeSH]
Rheum palmatumspecies[no description available]PolygonaceaeThe only family of the buckwheat order (Polygonales) of dicotyledonous flowering plants. It has 40 genera of herbs, shrubs, and trees.[MeSH]

Cross-References

ID SourceID
PubMed CID442731
CHEMBL ID443804
CHEBI ID3688
MeSH IDM0514717

Synonyms (39)

Synonym
8-hydroxy-6-methyl-9,10-dioxo-9,10-dihydroanthracen-1-yl beta-d-glucopyranoside
8-(beta-d-glucopyranosyloxy)-1-hydroxy-3-methyl-9,10-anthraquinone
CHEBI:3688 ,
13241-28-6
chrysophanol 8-glucoside
chrysophanol 8-o-beta-d-glucoside
chrysophanol 8-o-glucoside
chrysophanol 8-o-beta-d-glucopyranoside
pulmatin
LMPK13040007
CHEMBL443804
1-hydroxy-3-methyl-8-[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyanthracene-9,10-dione
1-hydroxy-3-methyl-8-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyanthracene-9,10-dione
chrysophanol-8-o-glucoside
unii-5d9g301stw
5d9g301stw ,
glucopyranoside, 8-hydroxy-6-methyl-1-anthraquinonyl, .beta.-d-
glucopyranoside, 8-hydroxy-6-methyl-1-anthraquinonyl
anthraquinone, 8-(.beta.-d-glucopyranosyloxy)-1-hydroxy-3-methyl-
o-.beta.-d-glucopyranosylchrysophanol
chrysophanol-8-mono-.beta.-d-glucoside
chrysophanol 8-o-.beta.-d-glucopyranoside
chrysophanol-8-o-.beta.-d-glucoside
9,10-anthracenedione, 8-(.beta.-d-glucopyranosyloxy)-1-hydroxy-3-methyl-
chrysophanol-8-.beta.-d-glucoside
chrysophanol-8-o-|a-d-glucopyranoside
DTXSID60157529
chrysophanol-8-o-beta-d-glucopyranoside
chrysophanol-8-beta-d-glucoside
AKOS032948547
HY-N2395
F17668
mfcd20260508
Q27106165
chrysophanol-8-glucoside
CS-0022597
MS-27238
9,10-anthracenedione, 8-(beta-d-glucopyranosyloxy)-1-hydroxy-3-methyl-
chrysophanol8-o-glucoside
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (2)

ClassDescription
beta-D-glucosideAny D-glucoside in which the anomeric centre has beta-configuration.
monohydroxyanthraquinoneAn anthraquinone in which the anthraquinone moiety is substituted by a single hydroxy group.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Bioassays (17)

Assay IDTitleYearJournalArticle
AID399962Cytotoxicity against human MCF7 cells2004Journal of natural products, Mar, Volume: 67, Issue:3
Anthrone and oxanthrone C-glycosides from Picramnia latifolia collected in Peru.
AID1667360Inhibition of alpha-glucosidase (unknown origin) using p-NPG as substrate by spectrophotometric analysis2020Bioorganic & medicinal chemistry letters, 04-15, Volume: 30, Issue:8
Tetra-aryl cyclobutane and stilbenes from the rhizomes of Rheum undulatum and their α-glucosidase inhibitory activity: Biological evaluation, kinetic analysis, and molecular docking simulation.
AID134177Compound (at 100 uM) was tested for inhibition against nitric oxide production in LPS-activated mouse peritoneal macrophages2000Bioorganic & medicinal chemistry letters, Feb-21, Volume: 10, Issue:4
Effects of stilbene constituents from rhubarb on nitric oxide production in lipopolysaccharide-activated macrophages.
AID399963Cytotoxicity against HUVEC2004Journal of natural products, Mar, Volume: 67, Issue:3
Anthrone and oxanthrone C-glycosides from Picramnia latifolia collected in Peru.
AID102411Compound was tested for enhancement of proliferation of MCF-7 cell line at a concentration 3 uM2001Bioorganic & medicinal chemistry letters, Jul-23, Volume: 11, Issue:14
Phytoestrogens from the roots of Polygonum cuspidatum (Polygonaceae): structure-requirement of hydroxyanthraquinones for estrogenic activity.
AID1072528Antiviral activity against Hepatitis B virus infected in human HepG2.2.15 cells assessed as decrease in HBV e antigen secretion2014European journal of medicinal chemistry, Mar-21, Volume: 75A review of non-nucleoside anti-hepatitis B virus agents.
AID1072521Selectivity index, ratio of cytotoxicity towards human HepG2.2.15 cells to IC50 for HBV DNA production2014European journal of medicinal chemistry, Mar-21, Volume: 75A review of non-nucleoside anti-hepatitis B virus agents.
AID132501Inhibitory activity against nitric oxide production in LPS-activated mouse peritoneal macrophages2000Bioorganic & medicinal chemistry letters, Feb-21, Volume: 10, Issue:4
Effects of stilbene constituents from rhubarb on nitric oxide production in lipopolysaccharide-activated macrophages.
AID399961Cytotoxicity against human LNCAP cells2004Journal of natural products, Mar, Volume: 67, Issue:3
Anthrone and oxanthrone C-glycosides from Picramnia latifolia collected in Peru.
AID1072529Antiviral activity against Hepatitis B virus infected in human HepG2.2.15 cells assessed as decrease in HBV surface antigen secretion2014European journal of medicinal chemistry, Mar-21, Volume: 75A review of non-nucleoside anti-hepatitis B virus agents.
AID399960Cytotoxicity against human Lu1 cells2004Journal of natural products, Mar, Volume: 67, Issue:3
Anthrone and oxanthrone C-glycosides from Picramnia latifolia collected in Peru.
AID1072522Selectivity index, ratio of cytotoxicity towards human HepG2.2.15 cells to IC50 for HBV surface antigen secretion2014European journal of medicinal chemistry, Mar-21, Volume: 75A review of non-nucleoside anti-hepatitis B virus agents.
AID1072523Antiviral activity against Hepatitis B virus infected in human HepG2.2.15 cells assessed as decrease in HBV DNA production2014European journal of medicinal chemistry, Mar-21, Volume: 75A review of non-nucleoside anti-hepatitis B virus agents.
AID1072527Selectivity index, ratio of cytotoxicity towards human HepG2.2.15 cells to IC50 for HBV e antigen secretion2014European journal of medicinal chemistry, Mar-21, Volume: 75A review of non-nucleoside anti-hepatitis B virus agents.
AID102410Compound was tested for enhancement of proliferation of MCF-7 cell line at a concentration 10 uM2001Bioorganic & medicinal chemistry letters, Jul-23, Volume: 11, Issue:14
Phytoestrogens from the roots of Polygonum cuspidatum (Polygonaceae): structure-requirement of hydroxyanthraquinones for estrogenic activity.
AID102409Compound was tested for enhancement of proliferation of MCF-7 cell line at a concentration 1 uM2001Bioorganic & medicinal chemistry letters, Jul-23, Volume: 11, Issue:14
Phytoestrogens from the roots of Polygonum cuspidatum (Polygonaceae): structure-requirement of hydroxyanthraquinones for estrogenic activity.
AID356320Antioxidant activity assessed as DPPH radical scavenging activity2003Journal of natural products, Aug, Volume: 66, Issue:8
Sulfemodin 8-O-beta-D-glucoside, a new sulfated anthraquinone glycoside, and antioxidant phenolic compounds from Rheum emodi.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (11)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's5 (45.45)29.6817
2010's4 (36.36)24.3611
2020's2 (18.18)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.52

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.52 (24.57)
Research Supply Index2.48 (2.92)
Research Growth Index5.00 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.52)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (9.09%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other10 (90.91%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]